In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential
Open Access
- 12 October 2014
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 5 (19) , 8869-8878
Abstract
The oncogenic bHLH-LZ transcription factor Myc forms binary complexes with its binding partner Max. These and other bHLH-LZ-based protein-protein interactions (PPI) in the Myc-Max network are essential for the physiological and oncogenic activities of Myc. We have generated a genetically determined and highly specific protein-fragment complementation assay based on Renilla luciferase to analyze the dynamic interplay of bHLH-LZ transcription factors Myc, Max, and Mxd1 in vivo. We also applied this PPI reporter to quantify alterations of nuclear Myc-Max complexes in response to mutational events, competitive binding by the transcriptional repressor Mxd1, or perturbations by small-molecule Myc inhibitors, including recently identified potent PPI inhibitors from a Kröhnke pyridine library. We show that the specificity of Myc-Max PPI reduction by the pyridine inhibitors directly correlates with their efficient and highly specific potential to interfere with the proliferation of human and avian tumor cells displaying deregulated Myc expression. In a direct comparison with known Myc inhibitors using human and avian cell systems, the pyridine compounds reveal a unique inhibitory potential even at sub-micromolar concentrations combined with remarkable specificity for the inhibition of Myc-driven tumor cell proliferation. Furthermore, we show in direct comparisons using defined avian cell systems that different Max PPI profiles for the variant members of the Myc protein family (c-Myc, v-Myc, N-Myc, L-Myc) correlate with their diverse oncogenic potential and their variable sensitivity to the novel pyridine inhibitors.Keywords
This publication has 43 references indexed in Scilit:
- Anticancer compound ABT-263 accelerates apoptosis in virus-infected cells and imbalances cytokine production and lowers survival rates of infected miceCell Death & Disease, 2013
- Reciprocal regulation of PKA and Rac signalingProceedings of the National Academy of Sciences, 2013
- Retroviral oncogenes: a historical primerNature Reviews Cancer, 2012
- MYC on the Path to CancerCell, 2012
- PKA regulatory subunits mediate synergy among conserved G-protein-coupled receptor cascadesNature Communications, 2011
- Promotion of direct reprogramming by transformation-deficient MycProceedings of the National Academy of Sciences, 2010
- Inhibition of Myc-induced cell transformation by brain acid-soluble protein 1 (BASP1)Proceedings of the National Academy of Sciences, 2009
- Myc’s broad reachGenes & Development, 2008
- Quantification of dynamic protein complexes using Renilla luciferase fragment complementation applied to protein kinase A activities in vivoProceedings of the National Academy of Sciences, 2007
- Small-molecule inhibitors of protein–protein interactions: progressing towards the dreamNature Reviews Drug Discovery, 2004